Tru Consulting is dedicated to delivering exceptional Anaplan implementation and consulting services with a focus on delivery excellence. What sets us apart is our commitment to an agile, collaborative, and client-centric approach that empowers our clients to achieve their goals and drive measurable strategic impact. By leveraging our deep industry expertise in higher education and public sector, cutting-edge technology, and innovative methodologies, we are able to provide tailored solutions that address our clients most pressing challenges and opportunities. Our goal is not just to deliver projects on time and within budget, but to become a true partner to our clients, and support them as serve their communities, institution, and constituents. Why Tru Consulting? —We have over 350+ years of collective experience working in the higher education and public sector industries. — We bring proprietary modeling frameworks and tried and true approaches tailored to education and public sector connected planning. — We have a proven track record and are 100% referenceable across our 60+ clients. To learn more, visit tru.consulting
IMUNON is a fully integrated, clinical stage biotechnology company focused on advancing a portfolio of innovative treatments that harness the bodys natural mechanisms to generate safe, effective, and durable responses across a broad array of human diseases. IMUNON has two platform technologies: Our TheraPlas® platform for the development of immunotherapies and other anti-cancer nucleic acid-based therapies and our PLACCINE platform for the development of nucleic acid vaccines for infectious diseases and cancer. The Companys lead clinical program, GEN-1, is a DNA-based immunotherapy for the localized treatment of advanced ovarian cancer currently in Phase II development. GEN-1 works by instructing the body to produce safe and durable levels of powerful cancer fighting molecules, such as interleukin-12 (IL-12) and interferon gamma (IFN-γ), at the tumor site. In addition, we are conducting pre-clinical proof-of-concept studies on a nucleic acid vaccine candidate targeting SARS-CoV-2 virus in order to validate our PLACCINE platform. IMUNONs platform technologies are based on the delivery of nucleic acids with novel synthetic delivery systems that are independent of viral vectors or devices. We will continue to leverage these platforms and to advance the technological frontier of plasmid DNA to better serve patients with difficult to treat conditions.
Axtra3D brings first-of-its-kind functionality to 3D printing with innovative products that are revolutionizing Additive Manufacturing. Outperforming SLA, DLP & LCD in speed, resolution, print area and surface quality, Axtra3Ds Lumia 3D Printer delivers a whole new 3D Printing experience with reliable, scalable, high speed, fine resolution printing—all in one machine.
At CounselX, we carefully listen to your unique needs and aspirations, showing our dedication to solve your three hard problems: Facilitating Enterprise Client and Law firms: Connecting enterprise clients with specialized legal talent for efficient outsourcing of specific legal tasks. This is me: https://shorturl.at/ctELY Supporting Legal Professionals: Offering a platform for legal experts to find flexible, additional work opportunities that utilize their skills and experience. This is me: https://shorturl.at/eqsAD Empowering Startups: Providing subscription-based legal services to help startups establish strong legal foundations and focus on growth through on-going support. This is me: https://shorturl.at/asKOT